Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Tornvall

Showing results (61-70 of 180) with videos related to

Pageof 18
Sort By:
Clinical Physiology and Functional Imaging|June 5, 2026
Stress native mapping does not distinguish patients with previous myocardial infarction with non-obstructive coronary arteries from healthy volunteersDaniel F Andersson, Rebecka Steffen Johansson, Per Tornvall, et al.
Atherosclerosis|March 3, 2006
Influence of eotaxin 67G>A polymorphism on plasma eotaxin concentrations in myocardial infarction survivors and healthy controlsYuri Sheikine, Birgitta Olsen, Baback Gharizadeh, et al.
Journal of the American Heart Association|July 14, 2025
Angina Pectoris Prevalence and Sick Leave Burden 1 Year After Myocardial Infarction With Nonobstructive Coronary ArteriesKerstin Welén Schef, Per Tornvall, Bertil Lindahl, et al.
BMC Cardiovascular Disorders|March 28, 2013
Long-term impact of postconditioning on infarct size and left ventricular ejection fraction in patients with ST-elevation myocardial infarctionPeder Sörensson, Lars Rydén, Nawsad Saleh, et al.
European Heart Journal|May 3, 2003
Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarctionAnna Norhammar, Klas Malmberg, Lars Rydén, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 19, 2007
Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemiaAlexander Kovacs, Per Tornvall, Roland Nilsson, et al.
Atherosclerosis|January 13, 2006
Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6Johannes Hulthe, William McPheat, Ann Samnegård, et al.
Simulation in Healthcare : Journal of the Society for Simulation in Healthcare|April 20, 2013
Technical skills assessment in a coronary angiography simulator for construct validationUlf J Jensen, Jens Jensen, Göran K Olivecrona, et al.
Cardiovascular and Interventional Radiology|April 10, 2008
The inflammatory response to femoral arterial closure devices: a randomized comparison among FemoStop, AngioSeal, and PercloseJens Jensen, Nawzad Saleh, Ulf Jensen, et al.
Clinical Chemistry|April 28, 2005
Hormonal regulation of circulating C-reactive protein in menAlexander Kovacs, Peter Henriksson, Anders Hamsten, et al.
Pageof 18

Showing results (61-70 of 180) with videos related to

Sort By:
Pageof 18
Clinical Physiology and Functional Imaging|June 5, 2026
Stress native mapping does not distinguish patients with previous myocardial infarction with non-obstructive coronary arteries from healthy volunteersDaniel F Andersson, Rebecka Steffen Johansson, Per Tornvall, et al.
Atherosclerosis|March 3, 2006
Influence of eotaxin 67G>A polymorphism on plasma eotaxin concentrations in myocardial infarction survivors and healthy controlsYuri Sheikine, Birgitta Olsen, Baback Gharizadeh, et al.
Journal of the American Heart Association|July 14, 2025
Angina Pectoris Prevalence and Sick Leave Burden 1 Year After Myocardial Infarction With Nonobstructive Coronary ArteriesKerstin Welén Schef, Per Tornvall, Bertil Lindahl, et al.
BMC Cardiovascular Disorders|March 28, 2013
Long-term impact of postconditioning on infarct size and left ventricular ejection fraction in patients with ST-elevation myocardial infarctionPeder Sörensson, Lars Rydén, Nawsad Saleh, et al.
European Heart Journal|May 3, 2003
Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarctionAnna Norhammar, Klas Malmberg, Lars Rydén, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 19, 2007
Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemiaAlexander Kovacs, Per Tornvall, Roland Nilsson, et al.
Atherosclerosis|January 13, 2006
Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6Johannes Hulthe, William McPheat, Ann Samnegård, et al.
Simulation in Healthcare : Journal of the Society for Simulation in Healthcare|April 20, 2013
Technical skills assessment in a coronary angiography simulator for construct validationUlf J Jensen, Jens Jensen, Göran K Olivecrona, et al.
Cardiovascular and Interventional Radiology|April 10, 2008
The inflammatory response to femoral arterial closure devices: a randomized comparison among FemoStop, AngioSeal, and PercloseJens Jensen, Nawzad Saleh, Ulf Jensen, et al.
Clinical Chemistry|April 28, 2005
Hormonal regulation of circulating C-reactive protein in menAlexander Kovacs, Peter Henriksson, Anders Hamsten, et al.
Pageof 18